Two Companies Witness Insider Selling after Releasing Strong Results, Plus Insider Buying at Three Other Firms

Executive at IT Solutions Provider Offloads Shares After Reporting Record Net Sales

Let’s move on to the fresh insider selling observed at CDW Corp (NASDAQ:CDW). Douglas E. Eckrote, Senior Vice President of Strategic Solutions and Services for CDW, discarded 71,372 shares on Thursday for $44.05 each, 8,162 shares at $43.96 apiece and 466 shares for $43.99 each on Friday. Following this series of sales, Mr. Eckrote currently owns 170,461 shares.

The recent insider selling comes after the provider of technology solutions to business, government, education and healthcare in the United States, Canada and the United Kingdom reported record sales for the third quarter. CDW Corp (NASDAQ:CDW) reported net sales of $3.71 billion, up from $3.50 billion posted in the third quarter of 2015. The company’s Board of Directors also approved a 49%-increase in the quarterly cash dividend paid to shareholders. The upped quarterly dividend of $0.16 per share equates to a current annual dividend yield of 1.44%. CDW’s shares are 5% in the green this year. Richard S. Pzena’s Pzena Investment Management was the owner of 146,082 shares of CDW Corp (NASDAQ:CDW) at the end of September.

CEO of Growing Medical-Device Maker Sell Some Shares

The man in charge of Stryker Corporation (NYSE:SYK) also unloaded some shares last week. Chairman and CEO Kevin A. Lobo liquidated 26,306 units of common stock on Thursday at prices varying from $115.57 to $116.14 per share. After the recent sale, Mr. Lobo currently owns an aggregate of 27,880 shares.

The medical-device maker has seen its market capitalization jump by 30% since the start of the year. Just recently, Stryker Corporation (NYSE:SYK) released better-than-expected results for the third quarter and lifted the low-end of its earnings per share guidance for the year. The company reported net sales of $2.83 billion, which rose by 17.1% year-over-year. Excluding the impact of acquisitions, Stryker’s net sales in constant currency increased by 7.5% year-on-year, reflecting increased unit volume due to higher shipments of neurotechnology, endoscopy, trauma and extremities, instruments and knee products. Donald Yacktman’s Yacktman Asset Management had 1.26 million shares of Stryker Corporation (NYSE:SYK) in its portfolio at the end of the third quarter.

Disclosure: None